“We are fortunate to have found an accomplished leader of Alexei’s calibre with a stellar reputation in the medical and assistive device space to drive HMR’s development and commercialization objectives
VANCOUVER, British Columbia (PRWEB) January 21, 2020
Human in Motion Robotics (HMR) today announced that Alexei Marko, previously an advisor to the Company, has been appointed Chief Executive Officer (CEO), effective immediately and will be joining the HMR Board of Directors. Incumbent CEO and co-founder of the Company, Dr. Siamak Arzanpour, will become the Company’s Chief Technology Officer (CTO) and Board director, Geof Auchinleck, has assumed the position of Chairman of the Board.
“Alexei’s expertise has already provided significant value in his role as an advisor to the Company,” states Board Chairman, Geof Auchinleck, “We are fortunate to have found an accomplished leader of Alexei’s calibre with a stellar reputation in the medical and assistive device space to drive HMR’s development and commercialization objectives.”
Under Marko’s leadership, the Company will continue to develop its next generation exoskeleton technology through the direction of the Company’s founders Dr. Siamak Arzanpour and Dr. Edward Park. As CTO and Chief Science Officer (CSO), respectively, Dr. Arzanpour and Dr. Park will continue to oversee the technical development program.
“Our exoskeleton technology shows great promise with our recently refined Beta prototype demonstrating significant advances in our field” says Dr. Arzanpour. “We look forward to continuing to build our team and drive development toward commercialization so that we can offer this important technology to the people that need it”.
Prior to his appointment as HMR’s Chief Executive Officer, Marko held C-suite positions in a number of medical device companies, both public and private, through which he earned a reputation for excellence in corporate growth, leadership, financing, and commercialization. In his previous CEO role, which he held for 10 years, Marko successfully led the company’s NASDAQ IPO and over the course of his career has raised over $180 million in financing. His success has earned him a number of business and leadership awards and has made him a popular mentor at Creative Destruction Labs and Accel-Rx.
“The team at HMR has done a remarkable job of bringing the concept of their technology to life with a working, industry leading technology that enables individuals with complete lower limb mobility impairment to stand and walk,” states Marko, “I’m honoured to join such a talented team and dedicated Board and look forward to contributing to its goal of offering wheelchair users a powerful assistive device with which they can mitigate typical secondary immobility health issues and experience life on their own terms.”
About Human in Motion Robotics
Developed for people living with a wide range of mobility challenges, particularly those with little to no lower limb function, HMR’s patented exoskeleton technology enables users to stand and walk without need of crutches or an attendant, perhaps for the first time ever. Our goal is to empower the millions of people with limited use of their legs to go about many of their daily activities without need of a wheelchair and mitigate the health consequences of being permanently confined to a sedentary position.
At this time, HMR’s technology and device are in development and not available on the market in any country. The Company will be providing regular progress updates over the coming months.